Newronika Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 17
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $9.3M
Latest Deal Amount
  • Investors
  • 8

Newronika General Information

Description

Manufacturer of a neuro-modulation device intended to restore brain and body functioning. The company's therapeutic device uses retro-activity system to record brain activity and modulate neuro-stimulation to collect, analyze and interpret bio-signals, enabling patients to receive the right stimulation at the right moment to perform normal daily activities and improve quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Via Dante 4
  • 20121 Milan
  • Italy
+39 02 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Newronika Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 25-Sep-2019 $9.3M 000.00 Completed Generating Revenue
2. Later Stage VC 14-Jun-2016 00.000 00.000 Completed Generating Revenue
1. Angel (individual) 01-Jan-2008 Completed Startup
To view Newronika’s complete valuation and funding history, request access »

Newronika Executive Team (5)

Name Title Board Seat Contact Info
Lorenzo Rossi Ph.D Co-Founder, Board Member & Chief Executive Officer
Alain Garcinuño Chief Financial Officer
Fabio Grisoni Chief Strategic Officer
Alberto Priori Ph.D Co-Founder, Board Member & Chairman of Scientific Board
Oleg Svanidze MD Chief Medical Officer
To view Newronika’s complete executive team members history, request access »

Newronika Board Members (10)

Name Representing Role Since
Alberto Priori Ph.D Newronika Co-Founder, Board Member & Chairman of Scientific Board 000 0000
Carlo Sanfilippo Self Board Member 000 0000
Claire Poulard Omnes Capital Board Member 000 0000
Claudio Giuliano Innogest Capital Board Member 000 0000
Lorenzo Rossi Ph.D Newronika Co-Founder, Board Member & Chief Executive Officer 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Newronika Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newronika Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Omnes Capital PE/Buyout Minority 000 0000 000000 0
Atlante Ventures Venture Capital Minority 000 0000 000000 0
F3F Other Minority 000 0000 000000 0
IMI Investimenti PE/Buyout Minority 000 0000 000000 0
Indaco Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »